occto
us
OXFORD COLON CANCER
TRUST
OCCTOPUS OXFORD COLON CANCER TRUST
Reystered tharity no.1104702
TRUSTEES. ANNUAL REpoirr AND F114ANaAL ￿ATEmENTs
YEAR TO 31 DECEMBER 2024

OCCTOPUS OXFORD COLON CANCER TRUST
TABLE OF coKfEvffS
Referentè and Administra￿e Details
Trnstees. Annual Rew)rt
Statement of Tluste￿ Responsibilities
li
Independent Examinerfs RÈport
12
Statement of Flnancial Art4vibÈs
13
Balance She¥(
14
ststement gfcash Flows
15
Notesto the Flnancial StatEmei
16
Page I

OCCTOPUS OXFORD COLON CANCER TRUST
REFERENCE AND ADMINISTRATIVE DEfAILS
Professor PeterAtkins
Mr Neil As
PYofessN Sr Neil mOrte￿ l£hèim)aTr}
M5 Katherine Baker
Professor Christopher Cunningham
Mr Nicholas Handy ITreasurer}
Mr Simon Holland
Mr Oliverjones
M5 Marianne Julebin lapFW)irted 18 March 20241
Professor Tim Maugham lJppointed 13 January 20251
Mrmark Row
Dr Michael Stein (appointe(113 January 20251
Mr Philip Williams
Mr Robjonckheer
Mr Stephen Dexter FCA
Colorectal Centre
The sLtr￿ery & Diagnostic Centre
Churchill Hospitsl
Headington
Oxford
OX3 7U
HSBC Bank pk
65 Commarket Street
(Axford
Independent Examlner.
Prfnclpal office:
Bankers:
OXI 3HY
oC￿0P￿S0￿t0Yd Coton C3FLceF Trust
ljuly 21XJ4 (number 11047021
httpJJwww.ocrtopus.or8.uk
fteglstratkn as a dwrltr.
webs1￿.

OCCTOPUS OXFORD COLON CANCER TRUST
TRUSTEEY ANNUAL REPORT
The trustees present thelr annual report and financial ststements for the year ended 31 December 2024. The financial
statements have been prepared in accordan￿ wtth the accounti￿ policies setouton pages 16to 19 and complywith
the charrvs trust deed, the Accounttng and Reporting by Charttse5: Statement of Recommended Pract[￿ appNcable
to charities preparing their accounts in accordance wrth the Financial Reporting Standard applicab]e in the UK and
Republicof Irela1￿ {FRS 1021. and aP￿￿￿e law asdixussed more fulty in fiote l<*n p￿e 16.
The aims of the tharity areto improvethe dta8nosFs bnd treatment of coknrectal (ancer. inflamrnatory bowel disease.
and bowel continence by promoting education. innovation and re5earth as well as thro￿ the wovision of specialist
equipment to allow new treatments to be delivered to patients.
This is achieved through providing grants and equipmentto the colorertal surgery department and Its clinical partners
at the Oxford University Hospttals NHS Foundation Tnjst and providing grants to the University of Oxford and other
academic and profe55iona) in5tilution5. The M)ttees confirm that they have referred to the Charity Commissiorfs
guidan￿ on public benefft when rerfiewing the ch￿5 aim5 and obiecti¥e4 in planning future activities. arKI
providinggrants forthe w.
The charity further5 tts chaitable Purpo￿ fortt* public benefft thro￿1 itsgw-making ￿liCy¥￿ICh looksto:
fund research related to the earfy dia8nosis and treatment of sufferers with cotorertal cancer and related
conditions
provlde support for education aTKI training in treatingcolorectsl cancer and related conditions: aNI
funding the purchase by the Oxford Univetsity Hospltals NHS Foundation Trust of specialised surgical
equipmentforthe treatmentof col0rertal￿￿cer. and rnllamlnatorybowelcondi￿$uChas ukeratiyecolitts
and Crohn'5 disease.
Grant making and fvnthng ￿￿1CV
The charity has establis1￿ its grant fftaking poliry to achiebE its oblects for the publtc benefft. The ultimate
beneficiaries of the grant making programme are those who suffer from cobre¢tal Cancer. ulcerative colitis. Crohn's
disease, inflammatory tr￿1. bowel continence problem5and at r45kofdeveiopingthese diseases. AccOrdi￿t0
the latest data from the World Heatth Organlsatlon. can￿r is the second most CoMn￿n cause of d&ith worldwide.
and the incidenceof can￿r Isincreasi￿ in all Countr￿5. Canceraccountedfor nearly 10 mlllion deaths in 2020. nearly
one in six death& The global cancèr burden is expected to reach 29 million new cancercases per year by 2040. a 60%
increase on the estimated 18.1 million Can￿r$ in 20181WHO World Can￿r Rep)rt 20221.
In the figures published by Cancer Researth UK I°CRUK°I, durin8 the period 201&18. there was a continued increase
in the numbers of new cancer diagnoses in E￿nd fr<>m 303.135 to 375AMI.
Colorectal can￿r is the third most common canter in ljoth mefi and women. In figures published try CRUK for this
same period there were 42 885 new case5 eath year. and around 53% 5u¥¥wed IOyear&
The charity provides grants to fund F￿raduate research fellowships focus5ed on the objectives of the charity. The
amount andterm ofthe reward is decided bythetrustee5 based onthe advice of th05etrustee5with clinicalexpertise.

OCCTOPUS OXFORD COLON CANCER TRUST
TRusfEES' AIINUAL REPORT IcopmNUED)
Typically, the ￿searCh funding will cover a period of two years. though this may be longer or shorter at the trustees,
discretion. The benefiaaries of the fellowships are monitofed thfOU8h regular reporting to the trustee meetings on
progress.
The charity funds equipment and trdinirg for those involved in tre*ing med•cal conditions that are w¥thin the scope
of the charitys work.
The dmrityprovides one off grants for Individual ￿stgradUate research in thefield of colorectal Can￿rand its related
conditions. These grants are 35sessed by the clinical trustees and, if considered appropriate. are reviewed by the
trustee body who determi￿ whetherto proceed wtth the 8ranL
The charity ful￿& the purdAse by the Oxford Uni¥ersity Hospita¢s NHS Fourthtion Trust of speciauged surgical
equipment to expand knowledge of new and innowative techniques that improve treatment of colorertal cancer and
its related conditions.
Any private benefrt re￿IVed by research institutions resear¢hers and healthcare bodies is purely incidental to the
objects of the tharivs WOT
The charity revlews the grdnt making polrry annually to ensure that it refleLts the charl￿$ objects ènd thereby
advaftces public benefiL
StNchKe. monagementarnl ¢ommunka(loft
The charity 15 a registered charwty, number 1104702, and Is Constituted under a trust deed dated 23 December 2003.
During the year. the 7rustees reviewed the Dedaration of Trust dated 23 D￿rnber 2003 constituiing the Charity.
Following this review. they approved changes to the objects. d￿llrt1OQ and tnEstee beneffts dauses. to which the
Chartty commi￿10￿ consented. and to some other administrative provisions. These changes were implemented by
an Amended and Confomied Declar*ion 0fTn￿ entered into bythe Trustees dated 13 Marth 2025. The key cha￿e
to the objects of the Chartty was to ￿fer to "colorettal ca(￿r and other tntestinal conditions- ll￿tead of "colorectal
cancer and related condition<. All other changes to the Deed updated its terms to refiect the Charity Commission's
Model Trust Deeds as currently issued by the Charrty Commission.
The charl￿S operations are controlled bythetrustees. Professor Sir Neil Mortensen 15 Chairnian and provldes medical
direction. Mr Rob Jonckheer acts as Secretary. provldlng support on d)arltable legal. regulatory and govemance
aspects. Mr NidM)las Handy att5 as Treasurer. providingwpport on all fifian¢ial aspects of the charit¢s activitie5.
The tharity has a part time administrator to assist with the administrat¥)n. publicity and fund vaisin8 of the charity.
who provides these servtces on a contracted basis. The admlnistrator ensures charity media profile is kept up to
date.
The trustee5 hold form21 meetsngs at leasr three times a year to consider all wÈcts of the chaFiVs activities, and to
monitor progre55 On the charitV5 strategic and operational plans (see achievements and perf0m￿nCe below). These
plans help trustees and supporters to work towards a shared and sustainable vision forthe futrjre, agreeing Priorities
and identifying appropriate actNities to a£h￿ve them.
A Nominations Committee. comprFsinE Professor Slr N￿7 Mortensen and Mr Philip ￿lliams. 15 responslble for
recommendations to thè trustees on the appointment of new trustees. Trustee F*rfonnance arKI re4ppointment is
Page4

OCCTOPUS OXFORD COLON CANCER TRUST
TRusfEE5' ANNUAL IIEPORT ICONTINUED}
considered anRually. Trustees are appointed through meeting with the Nofftinations Committee and, whe
practicable, through strurtured visits to the colorectal surgery department at the OxFord University Hospitals NHS
Foundation Tnjst. Trustee training isthrou8h peer supix)rt and attendance at relevant conferences orsemtnars.
Communications with SUPFM)rtÈrs and other interested parties are conductedthrough various means indudlngtailored
mailin& a quarterly newsletter, the chariW5 website. Just Givin& the annual report and events such as open day5 at
the colorectal carKer deparbxent atthe Oxford University Hospitals NHS Foundation Trust. Feedback from supporters
is solicf(ed in personal correspondence and communication.
During the year. the thaTity has mabntained Its emphasis on own and its partners, aC￿￿￿tsbIlJty. The tn￿ee5 seek
to follow the good practice'CharityTrustees Guide. issued by ICSA.. The Governance Institute.
The trustees meet regularly lat least three times a year formalty, addFtronally as I￿eded} to re¥￿W the ststus of
initiativès in hand and the charitys financial and investment position. These meeting5 are held either in person or.
where appropriate, through elertronic means. The development of Strategic Options whlch coukl affert planning is
also discLWd.
The trustees rèmain committed to mintmising administrative costs ai7d to Monit￿l￿g the perfom7ance of initiative5
implemented kn associat￿n with the Oxford Universty HospFtals Foundation T￿￿.
Mr Stephen Dexter FCA is the currently appointed independent examiner of the charity.
In 2024 the charity ffjairt¥ined its fund-raising activities in order to enable it to continue to prnvidÈ grants and
resoulces in accordance with its objectives.
As part of the grant making process the charity provided funds amounting to £30,(KM)12023 £Nil) to the R¢)yal Collège
of Surgeons of England to part fund o Robotics research fellowship using some of the funds provided by the Dr Elman
Poole Research Fellowship bequest. Charlotte El-sayed is a tninee surgeon with an interest in robotics, and thi5 is a
two year project. She has so far carried out reviews on wneasures y5ed to a55ess performar￿* metrics whilst learning
robottc surgery. The REINVENT study. Robotic Surgery Inno￿lon for EffKient TrnIn1￿ look at the barriers to and
solutions for best trainir8 in roEx>tlC Surgery.
The charity also committed to providingfunds affK>unting to £40,C4YJ1202a £ Nil) to the Uni¥ersity of Oxford to fund
a project to study how cancer-causing epithelial cells interact with their neighbouring cells-fibroblasts in colorectal
cancer and to expk)re therapeutic opportunittes by targeting this interaction. This was also funded through the Dr
Elman Poole Research Fellowship in agreement with the estste of the late Dr Elman Poole. Using cutting*dge
technologies including gene engineering techniques and 3D p3tient-derl￿d cell models optimised in the lab. the
project aims to reliabty model svbpopulations of colorert81 can￿rS. i.e., colorectal epithelial cells harbouring different
driver mutations. Findings from this project will help identfy key proteins that are involved in colorertal cancer
progression and ultimately may lead to novel personali5ed treatments that can benefit cancer patients.
Duringthe yearthe charitycontinued to fvnd through grènts to the Oxford University Hospitsls NHS Foundation Trust
a Clinical Dats Manager and Research Facilitator (the "Data Managerfl at a cost of £23,92812023 £23,0311- The
primary rote of the Oata Manager supports dats mana8ernenL education and research in the Colorertal DepartmenL

OCCTOPUS OXFORD COLON CANCER TRUST
TRIISTEES. ANNUAL REPORT (CONTINUED)
In particular Data Manager assists In the collectton, collarlon and dissemination of clinical data for pu￿OSe5 of clinical
governance and submission to national and intsmational audÉts. The Data Manager provides dirert visibility of the
work of the charity within the Department.
The charity ¢ontinued to fijnd at a costof £96.912 {2023 £30.(KKII the twoyear stULty into a potential link between the
enteric nervous system and Crohn's disease with the Universlty of Oxford Mediol Sclences DivisK+n. The project will
look into a potentlal link between the network of special ￿115 and nerves which pass alongside the blood ves*ls to
the guL It Ks thought this enteric neNous system IENSI influences gut secretion, motility, absorption and immune
function. There is s¢)me evidence that the ENS does not perform optTrmalty in Crohn's Oisease t￿t this has never been
properly studied before.
The ¢harity provided fundlng of £4,93012023 £ Nil) for the Universrty of Oxford to help fvftd a Patient and Ptjbllc
Information Group workshop. The objective of the workshop was to work with groups of patients to discuss priorities
and agree a 'top IU of what matters most to people affected by tsr￿r. In addition to providing information about
priority issues, the workshops establish Trlationships between the charity and an engaged group of patients.
The tharity also prcwided fvnding for the pro¥ision of specvalised items requested by the nursing team to adllress
speclfic Issues identlfied bythose nurses. lfi 2024 these items amounted to £76012023 £ NIII
The charoty measure5 its perfom)ance in two are35: ir7 the provision of grants al￿ the subsequent success of those
gra¥)ts In achieving the 8rant maknng policie5. The provision of grants is monitored at each trustee meeting where the
trustees With clinical expertise will provide advice and the trustee LKsdy as a whole will confirm whetherthe grant will
be made. As each grant provided tendsto have tanlque circumstances the charity measures perforniance on a ¢ase-
by-case basis and at trustee meetings ft)Ilows up the benefits from the grants.
The charity continue5 to monitor and addre55 Opportunities for re5ear¢h and the application ot surgical technology in
treatin8 colorectal cancer and its relèted conditions. 5ts PriOrit￿S at present a￿ to".
identifyiry future grants and education proFcts
continueto raise funds to address its chafitable objectives,. and
conseFve a fund for future te¢hnologlc41 developments (see also under Reserves policy below).
The charitycontinLFes to send e-newslettersto ensure past and potential donors are kept up to date with ouractivities.
The website is regularfy Lspdated to remove out of date links and to refresh content.
Fundraislry
The charity is commltted to following the Fundraisin8 Regulatorfs "Code of Fundraising Practice" 1.the Code") which
set5 the standards that apply to fLtndraising Carried out by all charitable institutions and third-party fundraisers in the
UK. The charity is regIste￿d with the Fundraising ReBulatorwhich fornialises its commitment to follow the Code.
The charl￿$ Administrator undertakes fijndraising projects in compliance with the Code. These projects i￿l￿de
supporting individuals who undertake sponsored activities. This support includes the provision of entrance to the
Oxford Half Marathon and the provision of Products branded with the charity1080 to iTrdTrv?duals undertaking specific
fundraislng activitie5 approved by the trustee5.
Page 6

OCCTOPUS OXFORD COLON CANCER TRUST
TRusfEES'ANNUAL REPORT (CONTINUED)
The charity also provides literature at the h)spitsls that it supwrts giving contsct details of the charity. The charity is
grateful for any legacies provided but is not invol¥e(J with the drafting of those legacies.
The principal risks faced by the charity have not changed significa*)tly from last year.. primarily the impact of a global
pandemi¢, the perfornian￿ of investments and operational risks from non-effettive grant making and the capaclty of
the charity to make effective grants.
The impatt of COVID-19 has demonstrated that a global pandemic outside the control or infiuence of the charity can
significantly affett the scale of its activities but not its ability to continue to operate effettNely. The trustee5 Consider
that as the chBrity has minimal ongoing commitments, an established ¢ore of donors 3nd sufficlent reseryes it can
continfjje to meet its charktsble objettives forthe foreseeable future.
The trustees consider the variability of investrnent returns on funds 4nve5ted or deposlted to constitute thè charitvs
major finan￿al risk. This Is mltlgated by having a diversified investment portfolio (through investing in fundsl and
monitoring the annualised returns of that Investment portfollo Included In the monthly management accounts. wlth
o formal report by the treasurer at exh of the tnLStee meetings. This di￿r$ificatIOn is achieved through the
investment managed fvnds provlded by the Charfties Aid Foundation ICAFI with an appropriate mix of Equity and
Fixed Interest investments.
The operational risk from research and grant awards is that they may be no￿ffeCtive in advancing knowtedge and
practice to those treating colorectal can￿r and related COr￿lti0ns. This is managed through retaining trustees
are Clinical experts to whom the recipients of the awards provide regular and detailed reports. In addition. the
recipients provide regular reports to the trustee bod¥ as a whole. The process of rep)rting and re¥Mv assists us, and
those we support, in keeping track of how research and knowledge is developing. This review wocess also focuses on
the public benefit derived from our funding of their wo￿.
The operational risk5from the fundin8of specialised sur8ical equipmentforthe use bytheOxfoTd Uni¥ersity Hospitsls
NHS Foundation Trust are=
the surgical equipment may be non-effective in treating the specialised condition of colorectsl cancer and
related conditwjns
the surgical equipment could be pmcured by the National Health Seryi¢e as part of its normal sper￿1n8 and
does not therefore meet the charl￿S aim of innovative techniques- and
the surgical equipment might be appropriated ty other a￿3$ of the Oxford University Hospita15 NHS
Foundation Trust which, whi15t providir8 a public benefit. would not necessariby achieve the charitys alms.
The operational risks from the fur￿1n8 of 5pecialised 5urg4cal equipment are managed by the appoititment of elinical
experts as trustees who a(fvisethe trusteesas a whole on the efficacy of the equipment and its irtnovative nature. The
clinical experts. ès the primary users of the equipment. provide assuran￿ that the equipment IS not appropriated by
others. All funding grants for specialised surgi￿1 equipment are agreed bythe trustee body as a whole to ensure the
risks noted above are appropriately managed.
Page 7

OCCTOPUS OXFORD COLON CANCER TRUST
7RUSTEES' ANNUAL REPORT (CONTINUED)
nandal review
The principal funding sources of the charity is made up of corporate entity donations ltypically in respect of restritted
funding of projects) and individual donations (typically from patients of the Oxford Unwersity Hospitals NHS
Foundation Trust or their relatives) together with gift aid where the donor has provided the appropriate dedaration.
In additlon. events may be held to raise funds where income is generated both by the sale of t4ckets to the event and
charity auctions or other donations provided during the event.
whe￿ donations exceed the immediatefunding requirements of the charity the excess Is invested in interest bearin8
bank accounts or investments in accordance with the investment policy (see below) and the dividends and interest
from these investments provides funding for the charity-
The grant making activity 15 discussed in detail in the"Achievements and Performènce" section of the ￿port above.
Dufing the year, the charity re￿iVed £9,662 of unrestricted non-rÈturring donations12023 £16.3821 and £720 of
unrestrirted recurrinE donation5 12023 £7761, indudin8 relevant Eift atd. Investment income. of which wa5
unrestricted. amounted to £13.69212023 £16.4261.
As part of its fund raisin8 activities the charity receNed £3.329 in swnsorship income from partldpants in the Oxford
Half Marathon12023 £4291
The charity ￿ntinUed its commercial ag￿ement vrith Everyclick where Everyclick makes a paymènt to the charity in
return for being able to list that charity on their services and to use the thar1￿S trade mark for the services. £2 of
income was received in ￿spert of this12023 £ Nill.
The Dats Manager, e￿loved bythe Oxford Urnivers(ty Hospitals NHS FoundationTrust andfundedthrou8h a grant bv
the charity of £23.92812023 £23.0311. supports an ert3blished researth team of clinicians, specialist nurses and
research nurses to actively initiate, promote and drlve the recruitmènt of Oxford University Hospita15 NHS Foundation
Trust patients for inclusion in national and intematlon81 clinical trials.
A5 the charity has no employees it has no employment or PenS￿n obtlgations.
The overall re5Utt of the actiwty during the year was a deftdt for the year of £155.20512023- deficit of £29,100) of
which £25,083 was represented by net gains on in¥estments12023-Gains of £19,914?.
The balance of funds decreased to £502,957 at 31 December 2024 from £658,162 at 31 December 2023. Total funds
induded a surplus of £97.22312023-£165.3191 of restricted income funds Unrèstricted funds arrmjunted to £405,734
12023- £492.843). Furtherdetaljs are discuss￿ tn the feser¥es sx)lity section whtch follows.
As noted in the reserves policy Section whlch follows the charity has sufficient ￿SeNeS to fulfil its commitment5.
Investments Ondlnvestment￿IkY
The trustees review the illvestment policy on an annual basis to ensure that it refiects the needs of the charity. The
objertive of the policy is to invest funds that are not anticipated to be used within the next 12 months.
The tr￿Stee$ have approved a Treasury Policywhere cash anticipated to be required within the current and following
months shoutd be held Èn instant access accounts provided by the charitls bankers. It is at the discretion of the
Page 8

OCCTOPUS OXFORD COLON CANCER TRUST
TRUSTEES, ANNLIAL REPORT (CONTINUED)
treasurer as to how much should be held in an intere5t-beartng account. In determin1r￿ the anticipated requirement,
the most recent approved budget or reported latestestimate should be the basisof the assessment.
Cash not anticipated to be r￿uired within the next two years should be hetd in a wrtfolio of Equity and Fixed Interest
investments held within a Fund available within the IFSL CAF ￿rtfOlIo.
The 4nvestments held within IFSL CAF sub funds atthe Start of the year were closed on 30 June 2024 al￿, following a
review of alternative funds available withsn the IFSL CAF portfolio, the trLSiees detemiined that the IFSL CAF ESG
Income and Growth Fund metthe investment obj'ectives of the d￿rIty.
The aim of the IFSL CAF ESG Income and Growth Fund is to irtuea5e the value of an investment over a minimum o*
flve years throu8h a combination of capital 8rowth- which is profit on investments held, and income received by the
Fund- whlch is money paid out of investments, such as dividends from shares and interest from l)onds. The Fund also
aims to deliver, overany rollrrtg five year perrod, an average of tnflatioft plus 3% per annL¢m. The Irwestment ManÈger
seek5 returns by investing in companhes that are focused on driwng and improvtng ESG change and are abso well
positioned to grow profit 4rKI o¥erall company Value.
Investments are shown in the balan￿ sheet at marketvalue of £322,342 at 31 t)ecember 202412023- £477.2S9}.
sh balances at the end of the year stood at £226.28312023- £209,519) of which £22,23112023- £21.8071 was held
in an interest-bearing accounL
The gains arising during the year from the revaluation of the ¢hartVs irwestments were £25,083 12023 gain5 of
£19,914). Investment income from investments aEYI Inte￿5t was £13,69212023- £16,426).
with the funding of signifKant tharitable expendiwre during the year and plans to maintsin charitable expenditure it
was decided to sell £180,CQO of investments12023 £ Nil) to ensure compliance with the charitys treasury policy.
A re￿nt Fund Managerfs report (issued in of the quarter ended 31 £knmber 2024} relating to IFSL CAF E5G
Income and Growth Fund, state(I:
"Market Commentsry
Political upheavals caused some short-temi markèt vDJ*illty. Recent rlght-wlng politlcal uprisings in Europe come at
a precèrious time during the Russian war in Ukraine. Europe also faces uncertainty over the US president-elecvs
proposed tariffs, which may create further instability for the global economy and international relations.
Tfump will inherit a strong ecoTWry. altlKJugh inflatlon remains elevated. and the budget deficFt is substantial. Tax
cuts and deregulation tould benefit small companies. but it is worth remembering that while Trump's policies may
appear market-friendly. his unpredictable behaviour can cause uncertainty and market volatllity.
Although government shutdowns are often considered noise, investor5 Should watth government bond ylelds, as
these indicate if markets are nef¥OUS ab)ut a (xJuntrf5 abilty to pay off debt. We Continue to monitor geopolitical
risk when constNrting portfolios but ￿maIn focused on quality companies well positioned to withstand politlcal
turbuleTr￿. Ultimately, it isthe businesses and their ability to grow earn¢￿ that matter.
The overall emphasis rernains on balanced portfolM)s of high-quality companies that can survive and thrive
independently of economic and polttical cydes. We have a well-established preference for high-quality equities as we
Page 9

OCCTOPUS OXFORD COLON CANCER TRUST
TRUSTEES, ANNUAL REPORT ICONTINVED)
expect companies with pricing power. strong balance sheets. and durable competltive advantages to be better placed
to add value overthe medium to longer temi.-
The charitys investment performance over 2024 has reflected the tumioil in the markets through the year, with a year
end overall wsÈtive return of 8.0% including dividend income received12023- negative return 7.9%). The trustees
have been carefully monitoring the situation as it has developed over the year and have tsken the view that in the
long-term funds not 4)ecificalty required within a yearhavethe best probabilityof exceedin8 Trnflat￿n by retainingthe
investmersts in their current funds. No additional In￿StMentS were made in the year.
The trustee5 continue to mor¢itor returns on a monthly basls and still consider that on a long-term basis the current
investment poliq remains appropriate to generate a return o¥èr the life of the irNestments in excessof inflation.
Taxotion
The charity is entided to those exemptions from UK tsxation vthith awe available in law to charities.
Reser￿*sPoIl￿
The trustees. poliry Is that so far AS possible thè annual intome of th@ tharlty shoLiSd be applied exclusively towards
its charitsble 3ctiwties, as at present it has minimal administrative expenses. However, the trLtstees recognise that
reserves will fluctuate. as its income in any year is to a large extent unpredictable and unlikely to match preciselv
opportunities for expenditure to meet tts objertNe&
The balance of funds at the 31 December 2024 amounted to £502.95712023- £658.1621 ofwhith;
£85,00012023- £155,000? restricted to the Dr Elman Poole Research Fellowship
£10,05412023- £10,0541 rèstr¥cted to the Exos(iffle Projects
£2.16912023- £2651 was restricted to supporting the stoma and colorectal nursing teams in Oxlord,
The balance of £405.73412023- £492,8431 was unrestricted.
Whilst there are no other identified slgnificant projects currently under review it is the opinion of the trustees that 3
minimum of £2￿.(￿ is likely to be needed to meet the periodtcal needs for technologscal updates of existing
e9uipment not funded by the National Heatth SeNice. The balan￿ of £205,734 is consldered a free reserve and is
available to provlde grants that meet the char￿$ policie5.
Remunerntlonpollcy
The trusteès consider the board of trLSStees as comprising the key management personnel of the charity in charge of
directing and controlling the charity and running and operatFng the Charity ors a day-to-day basi5. All trustees give of
their timè freely and no trustee remuneration or expenses were paid in the year.
Trustees are required to disclose all relevant interests and register them with the Chaifman and in accordance wlth
the charity'5 policy withdraw from decisions where a conflict of interest arises.
Page 10

OCCTOPUS OXFORD COLON CANCER TRUST
STATEMENT OF TRusfEES' RESPONSIBILrriES
The charity trustees are responsible for preparing a trustees. anrsual report and financial statements in accordance
with 3pplicable law and United Kingdom Accounting Stsndards Iunfted Kingdom Generalty Accepted Accounting
Prarticel.
The law applicable to charÉties ill England and Wa￿$ requires the d￿rIty trustees to prepare financial Statements for
each year which give 3 true and fair view of the state of affairs of the charity and of the incoming resources and
application of resources, of the charity forthat pefiod. In preparing thefinanual ststements. the trustees are requlred
to:
selert suitable accounting policies and then appty them conslstentlv
observe the methods and PTinciples the applicable Charities SORP
make judgements and estimates that a￿ reasonable and prudent
state whether app5icable accounting standards have been followed, subjert to any material departures that
must be disclosed and explained in the financial statements. and
prepare the financial ststements on the going concern basis unless it is inappropriate to presume that the
charity will continue in business.
Thetrustees are responsible for keeping properaccounting recordsthat disclose with reasonable accur3LV * anytime
the financial position ol the charity and to enable thelrt to gnsure thèt the financial statemertrts comply with the
Charities Act 2011. the applicable ChatitÈes (Accounts and Reports) Re8ulations, and the pro¥i5i0ns of the Trust deed.
They are also responsible forsafe8uardingthe assetsof the charity and tskingreasonable step5forthe prevention and
detection of fraud and other Èrregularities.
The trustees are responsible for the malntenance and integrity of the charity and financial infomiation included on
the charitVs webslte in actordance with legislation in the United Kingdom governing the preparation and
dissemination of financial statements.
Approved by the trustees on 17 March 2025 and signed on their behalf by:
Professor Sir Nell Mortensen
Oxford
Page 11

OCCTOPUS OXFORD COLON CANCER TRUST
INDEPENDENT EXAMINEJYS REPORT
to the Trustees of the Occtopus Oxford Colon Cancer Trust
I report on the accounts of the Occtopus Oxford Colon Cancer Trl￿ for the year ended 31 D￿mber 2024, which are
set out on pages 13 to 24.
Respecllve re5ponslbilities of trustees and examlner
The charit¢s tTU5tee5 are ￿pOnsIblef0rthe preparation ofthe accounts. The chaTity'Strustees considerthat an audit
is not required for this year under ￿ctIOn 144121 of the Charities Act 2011 (the 2011 Act). and that an independent
examination is needed.
t Is my responsFbility to..
examine the accounts under settion 145 of the Charities Actr,
followthe procedures laid down thegeneral Direttions given by the Charity Commission lundersection 145
15llbl of the 2011 Artl- ar
statè whether part4CL¢lar matters have come to my attention.
Basls of Independent examinerfs statemert
My examination was carried out in accordan￿ with the general Direttions gFven by the Charity Commission. An
examination includes a review of the accounting records ke0 by the charity and a comparison of the accounts
presented with those record5. It also includes consider3tson of any untssual items or disclosures Én the accounts and
seeking explanations from you as trustees concerning any such matters. The procedures iJndert3ken do not provide
all the evidence that would be required in an audit and tonsequently no opinion Trs given as to whether the accounts
present a'true fair vie￿, and the report is Ilmited to those matters set out in the next statement.
Independent examinerfs statement
In connection wtth my examinatttin, no matter has come to my attention:
111 which give5 me reasonable cause to belFeve that in, any material respect, the requirements:
to keep aCCOLJnting record5 in accordance with section 130 of the 2011 Act-
to prepa￿ accounts which accord with the accounting records and comply with the atcounting requirements
of the 2011 Act
have not been met; or
121 to which, in my opinTron. attention should be drawn in order to enable a proper understanding of the accounts to
be reached, other than Note l on page 16 which states that the financial stateTneTrts have been p￿pared to give
3 'true and fairf view and have departed from the Charities IAccoL*nts and Reports) Regulations 2008 only to the
extent requTred to provide a 'true and fair vith¢. This departu￿ ha5 involved following Accounting and Reportlng
by Charities preparingtheiraccou
In accordance with the Financial Reporting Standard applicable in the UK and
Republic of Ireland IFRS I
issued on 16 July 2014 rather than the Atcounting and Reporting by Charities=
State
ntof
ecom
ded Practice Èffective from l April 2005 which has Since been withdrawn.
Stephen Dexter FCA
Grove
17 March 2025
Page 12

OCCTOPUS OXFORD COLON CANCER TRUST
STATEMENf OF FINANCIAL AcnviTIES
For the year ended 31 December 2024
2024
2023
Restritted
Income
Total
Restrirted
Income
Total
Note
Unrestrirted
Unrestrkted
Income and endowments from:
OonatlOll5 and legacies
Other trading activtties
Inve5tfnents
2,723
10,382
3.331
13.692
27.405
13,105
3,331
13,692
30,128
17.158
429
17,158
429
16,426
34,013
16,426
34,013
Total
2.723
Expenditure on:
Rarsing funds
Charitab5e activ*ties
Total
Net èxpenditure and net
Movement in funds before
gains and losses on investments
59
13,827
125,770
139.597
13,886
196,530
210,416
15,255
62.665
77.920
15,255
67,772
83.027
70,760
70.819
5.107
5.107
168.0961 {112.192) 1180.2881
{5.107)
143,9071 149.0141
Net gains on iRvestment5
Net Movement in funds
Reconciliation of funds:
Total fijnds brought forward
Total funds carried forward
25.083
25,083
187,109) 1155.2051
19,914
19.914
{23.9931 129,1001
168,0961
{5.107)
12
165,319
97,223
492,843
405,734
658,162
502,957
170,426
165.319
516,836
492.843
687,262
658.162
12
The notes at pages 16 to 24 form part of these accounts.
Page 13

OCCTOPUS OXFORD COLON CANCER TRUST
BALANCE SHEEr
At 31 December 2024
2024
2023
Restrirted
Income Unrestricted
Restricted
Income
Total
Total
Note
Unrestricted
Fixed assets
Investments
322.342
322,342
477.259
477.259
Current assets
Debtor5
Cash
Total current assets
CuFrent liabilitie5
Creditors and accruals
1.803
89.060
90,863
1,803
226.283
228.086
1.462
44,200
45.662
1,462
209.519
210.981
137.223
137,223
165.319
165.319
io
li
40.000
97.223
7.471
83.392
47,471
180.615
30,077
15.585
30,077
180.903
Net current a55tts
165.319
Net Assets
97223
405.734
502,957
165.319
492,843
658.162
The Funds of the Charlty
Total income
12
97.223
405.734
502.957
165.319
492.843
658.162
The notes at pages 16 to 24 form part of these accounts.
Approved
trustees o
17 March 2025 and signed on their behalf by-
Professor Sir Neil Mortens
Page 14

OCCTOPUS OXFORD COLON CANCER TRUST
STATEMENT OF CASH FLOWS
For the year ended 31 December 2024
2024
2023
Restrirted
Note Income Unfestricted
Restrirted
Incolne
Total
Unrestrlrted
Total
Ca5hflows from Operatinq
Acti¥itie5:
Net cash used in operatlng
activities
13
128,0961
1148,8321 1176.9281
15.1071
140.1711 {45,2781
Cash flows from investing
activities:
Proceeds from sale of
investments
Dividends and interest from
investments
180,(MY)
180,0(K)
13,692
13.692
16,426
16,426
Chan8e in cash and (ash
equivalents in the year
Cash and cash equivalent brought
forward
Cash and cash equivalent carried
fo¥ward
12&096)
44.860
16.764
15.107}
(23.7451 128,852}
io
165.319
44.2Ck)
209.519
170,426
67,945
238,371
io
137.223
89.060
226.283
165,319
44.200
209.519
The notes at pages 16 to 24 form part of these accounts.
Page 15

OCCTOPUS OXFORD COLON CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2024
Accounting pollcles
lo) Bu515 ofpreporotion andassessment of going concern
The financial statements have been prepared under the historical cost convention with items recognised at cost or
transaction value unless otherwise stated in the relevant notelsl to these accounts. The financial statements have
been prepared in accordance with the Statement of Recommended Prartice.. Accounting and Reporting by Charitles
preparing their account5 in accordance with the Financial Reporting Standard applicable in the UK and Republic of
Ireland IFRS 102} issued OTh 16 July 2014 and the Financial Reporting Stsnd3Fd applicable in the United Kingdom and
Republic of [￿land IFRS 1021 ènd the Charrties Art 2011 and UK GenerallyAccepted practi￿ as itapplies from ljanuary
2015.
The financial statements have been prepared to give a 'true and fairf view and have departed from the Charities
(Accounts and Reports) Regulations 2(M)8 only to the extent required to provide a 'true and faFrviev/. This departure
ha5 involved following Accounting and Reporting by Charities prepartngtheir accounts in accordancewiththe Financial
Rèporting Standar4J applicable in the UK and Republic of Ireland IFRS 1021 i55LTred on 16 July 2014 rather thBn the
AccountinE and Reporting by Chalities: Statement of Recommended Practice effective from l April 2(X15 which has
since been withdrawn.
The charlty constitutes a public benefit entity as defined by FRS 102.
ThetfU5tees considerthatthereare no material uncertaintiesaboutthe charit￿5 abilTtyto continueas a goingconcern.
With respecttothe next reportin8 period. 2025. the mostSl8E)ifi£ant areas of unrertaintythat affettthe carrying value
of assets held by the charity are the level of investment return and the performance of investment markets (see the
investment policy and risk mana8emer>t sections of the trustees, annual report for more inform3tionl.
(b) Funds structure
Restricted funds are funds whTrch are to be used actordance with specific restrictions imposed by the donor or
through the temis of specific appeal5.
Unrestricted income funds comprise those fund5 whith the trustee5 are free to use for any purpose in furtherance of
the charitable objects.
fc) Income reco9nition
All intame is recognised once the charity has entitlement to the income, it is probable thatthe income will be received
and the amount of income receivable can be meassjred reliably. Donations are re¢ognised when the charity has been
notified in writingof boththe amount and settlement date, oracheque has been received. In the eventthat a donation
is subject to conditions that require a level of perfomiance before the charity is entitled to the funds. the income is
deferred and not recognised until eitherthose conditions are fully met, or the fulfilment of those conditions is wholly
within the control of the charity and it is probable thatthose conditions will be fulfilled in the reporting period.
Legacies are recognised on a case by case basisfollowing the granting of probate when the administratorlexecutor for
the estate has communicated in writing both the amount and settlement date. In the event that the gift is in the fomi
of an asset other than cash or a financial asset traded on a recoEnised stock exchange, recognition is Subject to the
Page 16

OCCTOPUS OXFORD COLON CANCER TRUST
NOTES TO THE FINANCIAL sfATEMEpirs
for the year ended 31 December 2024 IContinued}
value of the gift being rèliabty measurable with a degree of reasonable acojracyand the title to the asset having been
transferred to the charitv.
Interest on funds held on depositls included when re￿IVable and the amount can be measured reliably bythe charity;
this is norrFSally upon nOtif￿atIOn of the interest paid or payabk by the bank.
Distributlons are recognised once the distribution has been declared and notification has been ￿ceiVed of the
distrTrbution due. This is normally upon notificat*on by the lynd manager.
(dj Expenditure recognition
Liabilities Bre recognised as expenditure as 500n as there is a legal or constructive obligation committing the charity
to that expenditure, it is probable thatsettlement will be required and the amount of the obligation can be measured
reliably.
All expenditure is accounted for on an accruals basis. All expenses including support costs and governance costs are
allocated or apportioned to the applicable expenditure headings. For more information on thts attribution refer to
note111 below.
Grants payable are payments made to third partie5 in the furtherance of the charitable objects of the charity. In the
case of an unconditional grant offer this is accrued once the fecipient ha5 been notified of the grant award. The
notification g¢vesthe recipient a reasonable expectstion that they will receive the one-year ormultl-year grant. Grants
awardsthat are subjecttothe recipientfulfilling perfomiance conditionsafe onty accrued when the recipient has been
notified of the grant and any remaining unfulfilled condition attaching to that grdnt is outside of the control of the
eharity-
Provisions for grants are made when the intentoon to make a grant has been communicated to the reapient but there
is uncertainty as to the timlng of the grant or the amount of grant payable.
The provision for a multi-year grant is ￿cognIsEd èt its present value where 5ettlernent is due over more than one
year from the date of the award, there are no ut)fvlfilled performance conditions underthe control of the charity that
would peimit the charity to avoid making the future paymentl51. settlement is probable and the effect of discounting
15 material.
The discount rate used is the average rate of investment yield In the yèar in which the grant award is made. This
discount rate is regarded by the tTUStees a5 providing the most current available estimate of the opportunity cost of
money reflecting the tlme value of money to the charity.
(ej Irrecovemble VAT
The charity is not registered forVAT so irrecoverableVAT 15 charged against the expenditure heading for whlch It was
ncufred.
(ft Allocation of support ond governan￿ costs
The charity has no specific governance costs. which comprise all costs Involving the public accountability of the charlty
nd it5 Cgmpliance with regulation and good practice. as there are no tnjstee costs and the Independent Examiner
charges no fees for the examination. Other support costs in respect of charitablè artivities have been apportioned
Page 17

OCCTOPUS OXFORD COLON CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2024 (Continued)
based on an assessment of the individual c05t aThJ related artNity rt supports. The allocation of support and
governan￿ costs is explained in note 6.
(g} Costs of n7isingfund5
The costs of generating funds cor)slst of the allocation of support costs identified as directfy related to the cost of
generating funds and the costs of specific events whose purpose is to raise funds.
(h) Charitable octivities
Costsof charitable ￿1VItieS include grants made, SUFgbcal equipment provided andan apporthonment of support costs.
fi) Fixed ussetinvestments
Investments are a fomi of basic financial in5tnJment and are initially recognised at their transartion valve and
subsequently measured at their fair value as at the balante sheet date using tlie closin8 mèrket price. The statement
of financial activities includes the net gains and losses arising on revaluation and disposals through0￿ the year.
The charity does not acqui￿ put options. derivatives or other complex financial instruments.
The main form of financial risk faced by the charity is that of volatility in equity markets and investment markets due
to wider economic condition5, the attitude of investors to investment risk and changes in Sentiment concernlng
equities and within particular sectors or sub sectors.
} Investment gt7ins ond10sses
All ￿rnS and 5osses are taken to the Statement of Financial Artivities as they art5e.
Gains and losses are calculated as the difference between the fair values at the current and previous balance sheet
dates or, if purchased or sold during the year, the difference between fair value at the balance sheet date the asset
was held and the purchase prlee or sale5 proceeds
(kj Pensions
The charity has no employees and no pension obligations.
(IJ Lkvbto
Debtors are recognised at their recoverable amount Id)e amount the charity anticipates it will re￿1Ve from a debt or
the amount it has paid in advance for goods and servicesl.
{m) Ct7sh trt bonk andin hot
Cash at bank and in hand is held to meet short temi cash commitments as they fall due. Cash equivalents are short
term highly liquid investments readily tonvertibleto known amount5 of cash and are SL6bjertto an insignificant change
in value. A cash equlva￿nt has a short term maturity which is T￿t expected to exceed three ￿onthS.
Page 18

OCCTOPUS OXFORD COLON CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2024 {ContinuedJ
(nj Liabilitie5
Liabilities are amounts due to creditors and any provision made as a result of an obligation to transfer economic
benefit, normally as a tash payment, to a third party. A liability is recognised as the amount thatthe charity anticipates
It will pay to settle the obligation or the amount it has received as an advanced payment for goods or services it must
provide.
(oj Contingentliobilities
A contingent liability is identified and disclosed forthose grants resulting from=
a possible obligation which will only be confirmed by the occurrence of one or more uncertain future events
not wholly within the trustees. control.. or
a present obligation following a grant offer where settlement is either not considered probable,. or
the amount has not been communicated in the grant offer and that amount cannot be estimated reliably.
Related party transartions and trustees, remuneration and e¥penses
The trustees all give freeFy their time and expertise wtthout any form of remuneration or other benefit in cash or kind
12023 £Nill.
The trustees have made no claims for expense5 during the year (2023 ENil)-
Professor Christopher Cunningham. Mr Oliverjones and Ms Katherine Baker are directly employed by. and hold senior
positions at, the Oxford University Hospltals NHS Foundation Trust which the trustees consider to be a related party.
Professor Sir Neil Mortensen is an Honorary Consultant Surgeon at the Oxford UniversFiy Hospitals NHS Foundation
Trust and was President, Royal College of Surgeons of Engl31￿.
Donatlons and legacles
2024
2023
Restricted
Income
Restrscted
Unrestricted
Tot41
Income
Unrestrirted
Total
Recurrlng donallons
Under sift aid
Not under gift a¢d
Tax recoverable
480
525
525
120
120
120
120
120
120
131
131
720
720
776
776
Other donations
Under gift aid
Not under gift aid
Tay recoverable
8,420
992
8,420
3.617 |
348
9,835
4,108
2,439
16,382
17.158
9.835
4.108
2,439
16,382
17.158
2.625
98
250
2.723
9,662
10,382
12.385
Total donations
2.723
13.105
Page 19

OCCTOPUS OXFORD COLON CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS
for the year emled 31 December 2024 {Continued)
Other trading actlvities
2024
2023
Sponsorship
Licence fee income
3,329
429
3.331
429
Other tradlng activities were unrestricted.
Investment income
2024
2023
Fund distributions
Interest on bank deposlts
13,269
423
16.089
337
16.426
13,692
Investment Income was urbrestricted.
6. Allocation of governance and support costs
All governance activities are carried out by the trustees orthe independent examiner and asthey are not remunerated
and have claimed no expenses the governance costs are £Nil12023- £Nill.
The allocation of support costs between expendtture on an activty basts Is shown in the table below:
Cost Type
Raising funds
Donations and legaues
UnrgstrTrrtèd
intomo
funds
Restricted
income funds
Basis
Administrator's cost
Just Giving charges
Web site maintenance
Printing and stationery
loo%
85%
loo%
Time spent
Actual cost
',Actual cost
'Actual c05t
15%
0%
loo%
The time spent by the Administrator was allocate(I be￿een the varlous activitles based on an assessment of the time
taken in undertaking those activities
Page 20

OCCTOPUS OXFORD COLON CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2024 {Continuedl
Expenditure on raising funds
2024
2023
Restrirted Nursing funds
Donations and Segacie5
Just Givin8 charges
59
Unrestricted funds
Donations and legacies
Administrator costs
8ank and Just Giving charges
Web site development
Printing and stationery
Insurance
Regulatory and association Costs
12,174
721
664
11,943
644
1.534
137
183
85
14,526
183
85
13.827
Other trading attiviries- lundraising events
Sponsored activities
729
13.827
15,255
8. Expenditure tyn thafltable actlvitles
ZO34
Z023
Restricted
Income
Restricted
Intome
Unrestrirted
Total
Unfestrirted
Total
Restri¢ted funds
Funding research fellowship
Grant funding
Enteric NeTVOUS System IENSI
in Crohn's disease
70,000
70,000
96,912
96,912
30.000
5,369
35,369
30.000
S,369
35,369
Individual projects
96.912
96.912
Medical suppc•rt
Operating theatre equipment
Stoma team and colorettal
nursÈng staff
4,265
4,26S
760
760
760
760
4.265
4.265
Educ4tion and training
TaTME pilot training course
Clinical Data Manager and
Research Facilitator
Other grant5
5,107
5.107
23,928
4,930
28,858
125.770
23,928
4,930
28,858
196,530
23.031
23.031
5,107
5.107
23,031
62.665
28,138
67,772
70.760
Page 21

OCCTOPUS OXFORD COLON CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2024 (Continued)
Fixed asset investments
2024
2023
Movements in investments comprised:
Fair value at the beginnin8 of the year
Disposal
Ner gains
Fair value at the end of the year
477,259
1180,0001
25.083
322.342
457,345
19.914
477.259
Investments at fail value comprised:
Mafket Value
Sale and
Revaluation Pu¥thase
2024
2023
IFSL CAF ESG Incorne and Growth FLsnd Income
321.342
25.083 1180.oixI}
477,259
Fixed asset investments were unrestricted.
The signrficance of finanthal instruments to the ongoing financial sustainability of the charity 15 consldered in the
financial review and investment policy and performance sections of the trustees, Annual Report.
The main risk to the charity from financial instruments lies in the performance of the instruments and the liquidity
risks relating to the instruments.
Liquidity risk is assessed to be low as all assets are regulated by the FCA. The charity's investments can be traded
through Investment Fund Services Ltd with settlement typically within six days and consequently have good liquidity.
The charity has no investment holdings in ma￿et5 subjert to exchange controls or trading restrictions. The charity
manages these investment risks by operating an investment policy that provides for diversification of holdings
between income and equity funds. The charity does not m3ke use of derivatives and similar complex financial
instrurnents as it takes the view that investments are held for their longer tem) total return.
10. Current assets
2024
2023
Restrirted
Income
Restrirted
Income
Unrestricted
Total
Unrestrirted
Total
Debtors and prepayment5
Cijrrent account
1.803
66,829
22.231
89,060
90,863
1,803
204,052
22.231
226,283
228,086
1,462
22.393
21,807
44,200
45.662
1,462
187.712
21,807
209,519
210.981
137,223
165,319
Deposit accounr
Cash at bank
137.223
137,223
165.319
165.319
Cash at bank balances are the sole components of cash and cash equivalents. The chartry has no debL
Page 22

OCCTOPUS OXFORD COLON CANCER TRUST
NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2024 {Continued)
11. Creditor5 falling due within one year
2024
2023
Restricted funds
Funding research fellowship
Unrestricted funds
Administrators charges
Clin+cal Data Manager and Research Facilitator
tosts
700
6.693
Accruals and deferred income
Other creditors
30,000
77
30.077
78
7.471
12. Analysls ol fund movements
Balance
Type R or brought
UR*
fonvaTd
Balance
carried
forward
Galns and
losses
Fund namts
In¢orne
Expenditur•
Transfers
Dr Elman Poole
Research
Fellowship
Exosome Projects
Nursing team
support
Restrirted Income
155.000
10.054
170.0001
85,000
10,054
265
2.723
18191
165,319
2.723
170,8191
492.843
27.405
1139.5971
658.161
30.128
1210A16)
' Key.. R- re5trirted incomeftsnds, including speciol trnsrs. of t17e cl￿rIty.. ond U- unrestrirtedfunds
2,169
97,223
405.734
502,957
Unrestricted
25,083
25.083
Total
Purpose and Ae5trirtion5
Dr Elman Poole
Research
Fellowship
Exosome Projects
A legacy from the late Dr Elrrtan Poole to fund a research fellow to P4Jrsue the
object5 of the charitv
A legacy from the late Dr Elman Poole to fund research projects into
exosomes, in partiCLslar as they relate to tumours
Er*hanced post surgery care support for the stoma and colorectal nursing team
at the Oxford Univer51ty Hospitals NHS Foundation Trust.
Any atttvity of the charlty a5 approved by the trustee5 and in accordance with
the aims and objectives of the charity.
NursinE team support
Unrèstricted
Page 23

OCCTOPUS OXFORD COLON CANCER TRUST
NOTES TO THE Fif+JANCIAL STATEMEhrrs
for the year ended 31 December 2024 Iconlinued)
13. Re¢0￿111*10n of net movement in fvnds to net cash flow fr¢ffi operdtlng attivitles
2024
2023
Restrirted
Income
Restricted
Income Unyestricted
Total
Total
Unrestricted
Net movement in funds {as
per the statement of
financial artivltiesl
Divtdends and interest from
investments
168.0961
187,1091 { 155,2051
15,1071
{ 23,9931 129.1001
113,6921 113,6921
116.4261 116.4261
Gains on investments
125.0831 125.0831
119,9141 119,9141
Increase in debtors
Decrease/llncrea5el in
creditors
Net cash used in operating
activities
13411
13411
15701
15701
40,000
122,6071
17,393
20.732
20.732
128.096) 1148.832) 1176.928}
15,1071
{ 40,171} {45.2781
Page 24